Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: Results from the CATCH study Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Disability Evaluation
  • Physicians
  • Severity of Illness Index

abstract

  • MDGA was strongly associated with an increase in treatment at 3 and 6 months in ERA, whereas DAS28 was not. Physicians rarely stated that DAS28 was the reason for increasing treatment.

publication date

  • November 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.120520

PubMed ID

  • 22942265

Additional Document Info

start page

  • 2081

end page

  • 7

volume

  • 39

number

  • 11